Navigation Links
Cancer surgery patients have more complications, but less likely to die
Date:8/19/2013

DETROIT While more patients in the U.S. are suffering from complications such as blood clots and infections after major cancer surgery, fewer are dying from their operations.

The finding, part of a first-of-its-kind study by researchers at Henry Ford Hospital and others in the U.S., Canada and Germany, could lead to recommended changes in national health care policy and a reallocation of resources.

The study was published online in British Medical Journal Open. Jesse Sammon, D.O., Henry Ford Hospital urologist, research fellow and co-author of the paper, says the seemingly contradictory finding can be explained by improved response to patient crises, but a need for better prevention of post-surgical complications.

"Our report shows that while the incidence of preventable adverse events after major cancer surgery blood clots, infections, respiratory failure and pressure ulcers is increasing, the overall mortality of patients undergoing these procedures is decreasing in the U. S.," says Dr. Sammon.

"This paradox is explained in our report by the fact that physicians are probably getting increasingly better at identifying these adverse events early and managing them more effectively, thereby leading to lower mortality rates from adverse events and, by extension, lower overall mortality rates in the entire population of patients undergoing these procedures."

That's the good news. The bad news is that more needs to be done to prevent these complications.

"Just because physicians have become increasingly effective at managing these adverse events once they occur does not obviate the fact that there's still a lot of room for improvement in reducing the actual occurrence of these adverse events in the first place," Dr. Sammon says.

The study the largest ever to assess the quality of oncological surgical care in a nationwide sample focused on 2.5 million surgery patients over the age of 18 who underwent a major cancer procedure between 1999 and 2009.

The operations included partial or complete removal of a cancerous colon, bladder, esophagus, stomach, uterus, lung, pancreas or prostate.

Among the findings were "marked and worrisome increases" in the frequency of infections, pressure ulcers and respiratory failure after surgery.

But at the same time, there were also improvements in preventing anesthetic- and transfusion-related complications and hip fractures.

The researchers note the significance of this finding because Medicare curtailed the ability of hospitals to be reimbursed for "reasonably preventable events" since 2008 as an incentive to improve quality of care. The Affordable Care Act, which passed two years later, has added its own such initiatives.

"A rational approach to improving accountability for substandard care should begin with identifying the true burden of hospital-acquired adverse events," the study asserts.

In presenting their study, the researchers said it was launched at a time when medical errors in the U.S. cost an estimated $17 billion a year.


'/>"/>

Contact: Dwight Angell
dwight.angell@hfhs.org
313-850-3471
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. C8 Lawsuit Filed By Wright & Schulte LLC on Behalf of Ohio Woman Stricken with Thyroid Cancer Allegedly Due to C8 Tainted Drinking Water
2. Byetta Pancreatic Cancer Allegation Lawsuits Update: Resource4thePeople Awaiting Federal Court Decision on Possible Creation of Multidistrict Litigation
3. Latest Scientific Research Proves Accurate - The Health Laws in the Bible Would Stop All Cancer, Yisrayl Hawkins Says
4. Reprogrammed treatment-resistant lymphomas respond to cancer drugs
5. Cancer As a Result of Obesity On the Rise
6. Tumors form advance teams to ready lungs for spread of cancer
7. 1 in 5 women dont believe their breast cancer risk
8. Data: ATSP-7041 as first-in-class p53 pathway re-activator for solid/ hematologic cancers
9. Florida Woman Developed Bladder Cancer After Taking Actos to Treat her Type II Diabetes, Alleges Lawsuit Filed by Parker Waichman LLP
10. In nonsmoking women, breastfeeding for more than 6 months may protect against breast cancer
11. Targeting aggressive prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: